Autoimmune Support Protocol

An integrative, physician-supervised approach for adults living with autoimmune disease — working alongside your specialist to address the upstream drivers conventional care often does not reach.

At a Glance

What it targets: The upstream drivers of immune dysregulation — chronic inflammation, gut barrier dysfunction, stress physiology, sleep disruption — alongside specialist disease-modifying therapy. Not a replacement for specialist care.

Who it’s for: Adults with diagnosed autoimmune disease (RA, Hashimoto’s, lupus, psoriasis, IBD, MS, others), under appropriate specialist care, seeking integrative support for residual symptoms, flares, fatigue, or quality of life.

How it works: Physician-supervised combination of Thymosin Alpha-1 where appropriate, gut-immune axis support, inflammatory load reduction, stress and sleep optimisation, and the lifestyle layer.

What to expect: Inflammatory burden, energy, sleep, and gut function often shift in early and building phases. Flare frequency and severity may reduce over building and sustained phases. Outcomes vary enormously. ALIV does not guarantee remission, flare reduction, or medication reduction.

Who This Protocol Is For

Autoimmune disease is one of the most under-resourced areas of Indian healthcare. Many of our clients arrive specifically researching autoimmune disease treatment, rheumatoid arthritis, lupus, psoriasis, integrative or functional medicine autoimmune care in India — and want an integrative approach alongside their specialist rather than instead of one. Indian COPCORD studies estimate community prevalence of rheumatic musculoskeletal disease at 12-22%, with rheumatoid arthritis around 0.5-1.0% — a substantial and rising burden. Lupus, psoriasis, autoimmune thyroid disease, IBD, and other conditions add further to this picture.

If you live with autoimmune disease, you know the pattern: flare and quiet, ongoing medication, monitoring. Conventional specialist care excels at the medication side. What it often does not have time for is the upstream layer — gut, inflammation, sleep, stress, lifestyle inputs that determine quality of life and may influence disease trajectory.

This protocol was built for you if:

• You have a diagnosed autoimmune disease and are under appropriate specialist care
• You’re on disease-modifying medication or biologic therapy and want complementary support, not a replacement
• Standard biomarkers suggest disease is controlled, but fatigue, brain fog, gut symptoms, or quality of life remain affected
• You have frequent or unpredictable flares despite medication adherence
• You have strong family history and early markers (positive ANA, rising thyroid antibodies, joint stiffness) and want preventive integrative care
• You have multi-system autoimmune presentations (e.g., Hashimoto’s plus IBS plus skin) and want a coordinated approach

Important: This protocol is integrative, not alternative. ALIV does not accept clients seeking to replace evidence-based disease-modifying therapy with peptides, IV drips, or supplements. Your specialist remains the primary clinician for your autoimmune disease.

How It Works — The ALIV Approach

Autoimmune disease is, at its core, a problem of immune tolerance — the immune system’s ability to distinguish self from non-self. Specialist medication suppresses or modulates immune activity to reduce damage. Integrative care addresses the upstream environment: gut barrier function, chronic inflammation, stress physiology, sleep, micronutrient status.

Layer 1 — Thymosin Alpha-1: Immune Modulation, Not Suppression

Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide produced by the thymus, acting as an immune modulator — supporting T-cell function and immune balance rather than broad suppression. The distinction matters in autoimmune disease, where conventional treatments work by dampening immune activity. Tα1’s synthetic form, thymalfasin (Zadaxin), is FDA-approved for specific indications and used in over 35 countries. A 2024 comprehensive review covering over 11,000 patients across 30+ trials demonstrated a strong safety profile and immune-balancing effects. In autoimmune disease, Tα1 is off-label, used as an integrative add-on, not a disease-modifying therapy. It does not replace specialist medication.

Layer 2 — The Gut-Immune Axis

Approximately 70% of the immune system resides in or around the gut. Gut barrier integrity and microbiome composition matter in autoimmune disease — RA, lupus, MS, type 1 diabetes all show altered gut microbiome and barrier function. Restoring barrier integrity (where indicated, BPC-157 supports mucosal healing), targeted microbiome work, and removing inflammatory dietary inputs form this layer. The Gut Barrier Protocol coordinates where gut symptoms are prominent.

Layer 3 — Inflammatory Load, Stress, and Sleep

Autoimmune disease is fundamentally an inflammatory state, and inflammatory load is influenced by sleep, stress, diet, infections, and micronutrient status. Sleep disruption directly elevates inflammatory cytokines and is a documented flare trigger. Chronic stress — cortisol dysregulation, autonomic imbalance — is one of the most consistently identified flare drivers. This layer integrates the Sleep Protocol, nervous-system regulation, anti-inflammatory dietary support, and targeted nutrient repletion (commonly Vitamin D, Omega-3, Magnesium, Zinc, methylated B vitamins).

Layer 4 — Diagnostic Precision and Specialist Coordination

Your ALIV physician runs a comprehensive workup beyond standard surveillance: inflammatory markers (hsCRP, ESR, ferritin), micronutrient status (D, B12, magnesium, zinc), gut markers where indicated, full thyroid panel including antibodies, and review of current disease activity. Protocol coordinated explicitly with your specialist. Initiated only when disease activity is reasonably stable.

What to Expect

Honest framing: this is not a cure. Autoimmune disease is chronic and individual. What clients commonly notice is improved quality of life — less fatigue, better sleep, reduced gut symptoms, fewer or less severe flares — not elimination of disease.

Individual outcomes vary enormously. ALIV does not guarantee remission, flare reduction, medication reduction, or specific clinical outcomes.

What’s Involved

Before starting, your ALIV team runs the diagnostic assessment, reviews your current specialist management, and — with your permission — coordinates directly with your specialist. Contraindications detailed in the FAQ below.

The Lifestyle Layer — Where Autoimmune Quality of Life Is Built

In autoimmune disease, daily inputs are clinical inputs — diet, sleep, stress, and movement directly influence flare patterns and quality of life.

Anti-inflammatory nutrition: Mediterranean-style and fish-rich patterns have evidence for reduced disease activity in RA. The AIP diet has evidence in IBD and Hashimoto’s but is restrictive.

Sleep, stress, movement: sleep is a clinical intervention, not optional. Stress is among the most consistent flare triggers — breathwork, structured stress practices, professional psychological support where indicated. Movement is essential but calibrated — excessive intensity during flares can worsen disease activity.

Underrecognised triggers: smoking is strongly associated with rheumatoid arthritis severity and reduced medication response — cessation is one of the highest-impact interventions. Excessive alcohol adds inflammatory load. Untreated infections (chronic dental, gut, viral reactivations) quietly drive immune activation.

Frequently Asked Questions

Will this replace my rheumatologist or specialist medications?

No. Your specialist remains the primary clinician for your autoimmune disease. ALIV provides an integrative layer alongside specialist care.

Can autoimmune disease be reversed?

Established autoimmune disease cannot be fully reversed with any current therapy — the underlying loss of immune tolerance is durable. Achievable for many: reduced inflammatory burden, fewer or milder flares, improved quality of life, sometimes lower medication requirements (always specialist-directed). For early autoimmunity, upstream intervention may genuinely modify trajectory. Abandoning specialist medication to chase ‘cures’ usually causes harm.

Can integrative care actually help autoimmune disease?

Integrative care can meaningfully improve quality of life, reduce symptoms not fully addressed by medication (fatigue, brain fog, gut, sleep), and may influence flare patterns. Whether it modifies underlying disease course depends on condition, severity, and how well drivers like gut, stress, and inflammation are addressed.

Could peptide therapy trigger an autoimmune flare?

A legitimate concern ALIV takes seriously. Some immune-modulating peptides could theoretically activate immune pathways unhelpfully in autoimmune disease. Tα1 acts as an immune balancer rather than stimulator and has been studied across autoimmune populations. The protocol is initiated only when disease activity is stable, started at conservative dosing, and monitored.

Is there a specific protocol for my condition?

This umbrella protocol covers integrative principles across autoimmune disease. Specific conditions warrant dedicated pages — ALIV’s Hashimoto’s Thyroiditis Protocol exists; others are in development.

What about the AIP diet?

AIP has growing evidence in some autoimmune conditions, particularly IBD and Hashimoto’s. It is restrictive and not universally appropriate — most clients benefit from a Mediterranean-style pattern with targeted eliminations.

Who should NOT do this protocol?

Active severe autoimmune flare requiring specialist-led management; clients seeking to replace evidence-based specialist care; pregnancy or breastfeeding; active malignancy.

Take the Next Step

Living with autoimmune disease is a long-term clinical journey. Specialist care forms the foundation. ALIV adds the integrative layer conventional care often acknowledges but does not actively manage.

To find out if the Autoimmune Support Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. Dinetz E, Lee E. Comprehensive review of the safety and efficacy of Thymosin Alpha 1 in human clinical trials. Altern Ther Health Med. 2024;30(1):6-12. PMID: 38308608

2. Pica F, Chimenti MS, Gaziano R, et al. Serum thymosin α1 levels in patients with chronic inflammatory autoimmune diseases. Clin Exp Immunol. 2016;186(1):39-45. DOI: 10.1111/cei.12833

3. Misra DP, Sharma A, Dharmanand BG, Chandrashekara S. The epidemiology of rheumatic diseases in India. Indian J Rheumatol. 2024;19(2_suppl):S147-S160. DOI: 10.1177/09733698241229779

4. Shi W, Liang X, Zhang H, Li H. Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the Global Burden of Disease Database. Front Med. 2025;12:1526218. DOI: 10.3389/fmed.2025.1526218

5. Forsyth C, Kouvari M, D’Cunha NM, et al. The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies. Rheumatol Int. 2018;38(5):737-747. PMID: 29256100

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including any autoimmune condition. This protocol is integrative supportive care provided alongside — not as a replacement for — specialist rheumatology, dermatology, gastroenterology, endocrinology, or other condition-specific medical management. Outcomes vary significantly between individuals; ALIV does not guarantee remission, flare reduction, medication reduction, or any specific clinical outcome. Thymosin Alpha-1 is FDA-approved for specific indications and used off-label in integrative autoimmune support. Peptide therapies referenced are accessed via compounding pharmacies in India; informed consent and physician monitoring are essential. Please consult a qualified healthcare professional before starting any therapy programme.